CWM
PLRX icon

Congress Wealth Management’s Pliant Therapeutics PLRX Stock Holding History

Congress Wealth Management’s Portfolio PLRX Stock Details PLRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		$232K Sell
199,920
-222,391
-53% -$314K ﹤0.01% 1117
2025
Q1 		$570K Buy
+422,311
New +$2.56M 0.01% 775

Other funds holding PLRX

TCM
Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BOCH
Blue Owl Capital Holdings New York $665M AUM 95.48% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $32.4B AUM 58.5% 1-Year Est. Return
MAP
Madison Avenue Partners New York $2.32B AUM 132.6% 1-Year Est. Return
TGI
TRV GP IV Boston, Massachusetts $254M AUM 426.76% 1-Year Est. Return

Congress Wealth Management's PLRX Position: Q2 2025 in Review

Congress Wealth Management reduced its Pliant Therapeutics (PLRX) stake by 53% in Q2 2025, selling an estimated $314K and leaving 199,920 shares worth $232K. The position accounts for ﹤0.01% of the portfolio, ranked #1117.

Congress Wealth Management first reported a position in PLRX in Q1 2025 and has held it in 2 quarters since. The position peaked at $570K in Q1 2025. 114 funds tracked by Wall St. Rank hold PLRX as of Q2 2025.

  • Congress Wealth Management held 199,920 shares of Pliant Therapeutics worth $232K as of Q2 2025.
  • Congress Wealth Management sold 222,391 Pliant Therapeutics shares in Q2 2025, an estimated $314K.
  • Pliant Therapeutics made up ﹤0.01% of Congress Wealth Management's portfolio in Q2 2025, its #1117 holding.
  • Congress Wealth Management first reported a position in Pliant Therapeutics in Q1 2025 and has held it in 2 quarters since.
  • Congress Wealth Management's Pliant Therapeutics position peaked at $570K in Q1 2025.
  • 114 funds tracked by Wall St. Rank held Pliant Therapeutics as of Q2 2025.

Based on Congress Wealth Management's 13F filing for Q2 2025, filed 13 Aug 2025.